Table 1.

Sequence and genetic distance information for HIV-1 quasispecies.

Sampling time	Estimated months since infection	Plasma specimen					Whole blood specimen
		Specimen ID	No. of sequences	No. of unique quasispecies	Intrapersonal genetic distance(%)		Specimen ID	No. of sequences	No. of unique quasispecies	Intrapersonal genetic distance(%)
					Average	Range				Average	Range
1	1 month	FP1	83290	51	0.7	0.0~0.9	FW1	106443	12	0.6	0.0~0.6
2	4 months	FP2	180118	35	0.9	0.0~1.3	FW2	125743	18	0.6	0.0~1.6
3	7 months	FP3	150266	103	1.6	0.0~2.6	FW3	171124	31	0.6	0.0~1.2
4	12 months	FP4	136249	310	1.7	0.0~3.6	FW4	150694	60	0.6	0.0~2.9
5	15 months	FP5	135538	48	0.6	0.0~1.2	—	—	—	—	—
6	18 months	FP6	90088	23	0.6	0.0~0.6	—	—	—	—	—
7	28 months	FP7	160427	111	1.7	0.0~3.8	FW7	83329	91	2.9	0.0~5.4
8	37 months	FP8	112776	322	2.3	0.0~4.8	FW8	97328	190	3.1	0.0~6.1
9	54 months	※FP9	NA	NA	NA	NA	FW9	175811	74	0.6	0.0~1.2
1	1 month	MP1	172087	41	0.6	0.0~1.5	MW1	134179	70	0.8	0.0~4.3
2	4 months	MP2	69949	129	1	0.0~2.0	MW2	259369	87	0.6	0.0~0.9
3	7 months	MP3	106222	311	1.6	0.0~3.2	MW3	211341	22	0.8	0.0~1.9
4	12 months	MP4	103859	296	2	0.0~4.5	MW4	152531	188	1.2	0.0~2.5
5	15 months	MP5	78413	51	1.2	0.0~1.9	—	—	—	—	—
6	37 months	MP8	156241	44	0.7	0.0~0.7	MW8	75115	123	2.7	0.0~5.4

The samples from F at different sampling time is numbered as FP(x), FW(x) while samples from M at different sampling time is numbered as MP(x), MW(x). “(x)” means the times of sampling. ※Subject of FP9 had been treated with antiretroviral therapy for 16 months before sampling, and the others were not treated. “—” means absent of samples. “NA” means “Not available”.